In this sectionMore on this Topic

Innovations in Drug Development - September 9, 2015

Share:
Linked InPrintEmail

A. James Clark Distinguished Professorship in Molecular Genetics
Innovations in Drug Development: How Children’s National is Taking a Leadership Role in Faster, Better, and Cheaper Drugs 

Presented by: 

Eric Hoffman, PhD
Director, Research Center for Genetic Medicine, Children’s National
Professor and Chairman, Department of Integrative Systems Biology, George Washington University
Co-Founder, ReveraGen Biopharma

GiveAct

Invest in future cures for some of life's most devastating diseases

See other ways to give

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.Make it happen

You Might Also Be Interested In:

Brain Tumor Institute

We bring together a comprehensive team of pediatric oncology and neurology experts, giving children with brain tumors effective, personalized care.

Brain Tumor Institute (Neuro-Oncology Program)

Our Brain Tumor Institute uses a unique approach, tapping in to the expertise of both neurologists and neuro-oncologists, to deliver the best possible care.

Muscular Dystrophies

Muscular dystrophy describes a genetic disorder of the muscles that causes the muscles in the body to become very weak. 

Genetics Expert Talks about Tensions Between Parents and Regulators over Duchenne Treatments

In a feature story in Bloomberg Businessweek about Duchenne muscular dystrophy, Eric Hoffman, PhD, discusses the current tension that exists between families and drug regulators.